Metabolite details
Reactome pathways
- No Reactome pathways listed for this metabolite.
Observed in studies
- Effect of L-carnitine administration on lipid and metabolite content in sheep infraspinatus muscle after tendon release
- Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
- Metabolomic Insights into the Browning of the Peel of Bagging ‘Rui Xue’ Apple Fruit
- Changes and correlations of intestinal flora and liver metabolite profiles in mice with gallstones
- Metabolomics and lipidomics reveal perturbation of sphingolipid metabolism by a novel anti-trypanosomal 3-(oxazolo[4,5-b]pyridine-2-yl)anilide
- Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
- Long-term low-dose ionizing radiation induced chromosome-aberration-specific metabolic phenotype changes in radiation workers
- Effects of Radiofrequency Field from 5G Communications on fecal microbiome and metabolome profiles in mice
- Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
- Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage
- Unraveling the metabolic effects of benzophenone-3 on the endosymbiotic dinoflagellate Cladocopium goreaui
Observed in differential profiles
- Control_16.6_months_vs_Treatment_16.6_months
- G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
- Non_Bagged_Fruits_vs_Bagged_Fruits_With_Browning
- Control_vs_Lithogenic_Diet
- Control_vs_OXPA_Treatment
- Control_vs_OXPA_Treatment
- G1_PBS_vs_G2_DSS
- LLIR_vs_Control
- Sham_vs_Radiofrequency
- Control_vs_ZYP_High_Dose
- Control_0d_vs_Treatment_180d
- Control_0d_vs_Treatment_180d
- Control_vs_BP3_Low_Concentration